Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS)
Jenny Feng, Mary Rensel Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USACorrespondence: Mary RenselMellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, 9500 Euclid Ave. U10, Cleveland, OH 44195, USATel +1 216 444 8631Fax +1 2...
Saved in:
Main Authors: | Feng J (Author), Rensel M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A review of treatment of relapsing-remitting type of multiple sclerosis (RRMS)
by: Arkadiusz Bydliński, et al.
Published: (2024) -
Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study
by: Rozita Doosti, et al.
Published: (2021) -
Advances in the treatment of relapsing–remitting multiple sclerosis – critical appraisal of fingolimod
by: Gasperini C, et al.
Published: (2013) -
The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
by: Martin Vališ, et al.
Published: (2023) -
Different Doses of Fingolimod in Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Xin Wu, et al.
Published: (2021)